COVID-19大流行对美国癫痫中心实践的影响
本研究比较了260家美国国家癫痫中心协会(NAEC)认证的3级和4级癫痫中心在2019年与2020年报告的数据,发现2020年癫痫监测单元(EMU)收治量下降23%(减少21,515例),治疗手术减少371例(5.7%),其中迷走神经刺激植入术减少486例(19%),颞叶切除术减少227例(16%),而胼胝体切开术增加35%(54例)。作者认为疫情期间癫痫患者就医机会减少,成人患者、依赖3级中心者及美国东半部人群受影响最大。
要点
- 2020年EMU收治量下降23%(减少21,515例),3级中心中位减少55例(44%),成人中心中位减少57例(39%)。
- 治疗手术减少371例(5.7%),VNS植入减少486例(19%),颞叶切除术减少227例(16%),胼胝体切开术增加35%(54例)。
- 收治减少的原因包括重新分配EMU床位、限制择期入院、人员减少及患者不愿择期入院。
核心结论
- 2020年COVID-19大流行期间,美国癫痫患者获得医疗服务的机会减少,成人患者、依赖3级中心者及美国东半部许多人群受影响最大。
研究设计与样本
- 比较2019年(COVID-19大流行前)与2020年全部260家NAEC认证的3级和4级癫痫中心报告的数据。
- 分类变量用频率描述,连续变量用中位数描述,并按中心级别、中心人口类别和地理位置分析。
- 对中心主任关于COVID-19影响的定性回答采用主题分析进行总结,数据来源包括NAEC中心年度报告及补充COVID-19调查。
主要发现
- 2020年EMU收治量下降23%(减少21,515例),3级中心中位减少55例(44%),成人中心中位减少57例(39%)。
- 收治量下降在东中北部、东南中部、中大西洋和新英格兰美国人口普查区更为明显。
- 治疗手术减少371例(5.7%),其中VNS植入减少486例(19%),颞叶切除术减少227例(16%)。
- 所有其他手术量增加,包括胼胝体切开术增加35%(54例)。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND AND OBJECTIVES: Persons with epilepsy, especially those with drug resistant epilepsy (DRE), may benefit from inpatient services such as admission to the epilepsy monitoring unit (EMU) and epilepsy surgery. The COVID-19 pandemic caused reductions in these services within the US during 2020. This article highlights changes in resources, admissions, and procedures among epilepsy centers accredited by the National Association of Epilepsy Centers (NAEC). METHODS: We compared data reported in 2019, prior to the COVID-19 pandemic, and 2020 from all 260 level 3 and level 4 NAEC accredited epilepsy centers. Data were described using frequency for categorical variables and median for continuous variables and were analyzed by center level, center population category, and geographical location. Qualitative responses from center directors to questions regarding the impact from COVID-19 were summarized utilizing thematic analysis. Responses from the NAEC center annual reports as well as a supplemental COVID-19 survey were included. RESULTS: EMU admissions declined 23% (-21,515) in 2020, with largest median reductions in level 3 centers [-55 admissions (-44%)] and adult centers [-57 admissions (-39%)]. The drop in admissions was more substantial in the East North Central, East South Central, Mid Atlantic, and New England US Census divisions. Survey respondents attributed reduced admissions to re-assigning EMU beds, restrictions on elective admissions, reduced staffing, and patient reluctance for elective admission. Treatment surgeries declined by 371 cases (5.7%), with the largest reduction occurring in VNS implantations [-486 cases (-19%)] and temporal lobectomies [-227 cases (-16%)]. All other procedure volumes increased, including a 35% (54 cases) increase in corpus callosotomies. DISCUSSION: In the US, access to care for persons with epilepsy declined during the COVID-19 pandemic in 2020. Adult patients, those relying on level 3 centers for care, and many persons in the eastern half of the US were most affected.
引用
- Ahrens SM, Ostendorf AP, Lado FA, et al. Impact of the COVID-19 Pandemic on Epilepsy Center Practice in the United States. Neurology. 2022. PMID: 35292559. doi:10.1212/WNL.0000000000200285
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。